China SXT Pharmaceuticals, Inc. Earnings Per Share (Basic)
China SXT Pharmaceuticals, Inc. (SXTC) reported Earnings Per Share (Basic) of -$9.13 per share for the 12-month period ending 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-01
| Period end | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|
| 2026-03-31 | -$9.13 20-F · filed 2026-07-01 | |||
| 2025-09-30 | -$0.06 6-K · filed 2025-12-31 | |||
| 2025-03-31 | -$348.17 20-F · filed 2026-07-01 | -$2.32 20-F · filed 2025-07-31 | ||
| 2024-09-30 | -$0.25 6-K · filed 2025-12-31 | |||
| 2024-03-31 | -$4285.66 20-F · filed 2026-07-01 | -$3.57 20-F · filed 2024-08-13 | ||
| 2023-09-30 | -$19.34 6-K · filed 2025-03-28 | |||
| 2023-03-31 | -$177.84 20-F · filed 2025-07-31 | -$0.89 20-F · filed 2023-07-31 | ||
| 2022-09-30 | -$14.61 6-K · filed 2024-04-05 | -$0.58 6-K · filed 2023-02-24 | ||
| 2022-03-31 | -$137.92 20-F · filed 2024-08-13 | $5.52 20-F · filed 2022-07-18 | ||
| 2021-09-30 | -$3.98 6-K · filed 2023-02-24 | |||
| 2021-03-31 | -$3.82 20-F · filed 2023-07-31 | $3.82 20-F · filed 2022-07-18 | ||
| 2020-03-31 | $33.28 20-F/A · filed 2023-05-19 | |||
| 2019-09-30 | -$0.10 6-K/A · filed 2020-05-22 | |||
| 2019-03-31 | $0.07 20-F · filed 2019-08-15 | |||
| 2018-09-30 | $0.05 6-K/A · filed 2020-05-22 | |||
| 2018-03-31 | $0.06 20-F · filed 2019-08-15 | |||
| 2017-03-31 | $0.06 20-F · filed 2019-08-15 |